Related Experiment Video
Updated: May 22, 2026

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm
Published on: August 1, 2025
Are we ignoring the dilated thoracic aorta?
Jose M Castellano1,2, Jason C Kovacic1,2, Javier Sanz1,2
1Zena and Michael A. Wiener Cardiovascular Institute.
Abstract:
The pathophysiology of thoracic aortic aneurysm (TAA) formation involves a complex interplay of genetic predisposition, cardiovascular risk factors, and hemodynamic forces. The medical community has resorted to the use of pharmacologic agents based on weak data transplanted from either abdominal aortic aneurysms (AAAs) or Marfan syndrome. However, aneurysms differ significantly based on their anatomic location and etiology. Epidemiologic and experimental data demonstrate that different genetic and nongenetic risk factors as well as diverse physiologic processes are responsible for the development and progression of sporadic TAA, familial TAA, and AAA. Therefore, these disease processes need to be considered as distinct entities and not hastily grouped together. The extrapolation of data from one aneurysmal disease process to another is still ill-founded and potentially harmful. Clinical trials in TAA are required before medical therapies, such as β-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, statins, or macrolide antibiotics, can be recommended.
Related Concept Videos
Thoracic Aorta
The Aorta
The average diameter of the aorta is approximately 2-3 cm, but the size can vary depending on the section of the aorta and the individual's age, sex, and body size. The aorta is...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm I: Introduction
Abdominal Aorta
The celiac trunk, a singular artery, divides into the left gastric artery, which...
The Arch of Aorta
Encircling the heart, the coronary arteries form a ring-like structure before...

